StonvexLoading…
StonvexStonvexStonvexCore line items from RAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.07B | $2.15B | $2.16B |
Operating Income | $-1.18B | $459.60M | $511.80M |
Net Income | $-1.22B | $354.60M | $416.80M |
EPS (Diluted) | $-10.84 | $3.15 | $3.70 |
Total Assets | $3.82B | $4.72B | Not available |
Total Liabilities | $2.19B | $956.60M | Not available |
Cash & Equivalents | $318.80M | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | $358.40M | $420.20M | $432.60M |
Shares Outstanding | 112.90M | 100 | 112.70M |